Reduction of voluntary morphine consumption following treatment with zimelidine.
Male Wistar rats were presented with an everyday free choice between water and a morphine-sucrose solution. Following a 5-day baseline period animals were injected with either zimelidine (10 or 20 mg/kg, i.p.), a neuronal serotonin uptake inhibitor, or Ringer's solution (2 ml/kg, i.p.) for 5 consecutive days. Treatment with zimelidine was shown to significantly attenuate morphine drinking suggesting that an increased availability of serotonin may interfere with the positive reinforcing properties of morphine. The results are also discussed in terms of a possible interaction with brain norepinephrine. The possibility that the reinforcing effects of both morphine and ethanol are subserved by common mechanisms is suggested.
D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects; D001977:Brompheniramine / Q000031:analogs & derivatives / Q000494:pharmacology*; D006801:Humans; D008297:Male; D009021:Morphine Dependence / Q000523:psychology*; D009638:Norepinephrine / Q000378:metabolism; D011725:Pyridines / Q000494:pharmacology*; D051381:Rats; D012646:Self Administration; D012702:Serotonin Antagonists / Q000494:pharmacology*; D015031:Zimeldine
D011725:Pyridines; D012702:Serotonin Antagonists; D015031:Zimeldine; D001977:Brompheniramine; D009638:Norepinephrine